Skip to main content
Top
Published in: Digestive Diseases and Sciences 10/2013

01-10-2013 | Review

Obliterative Portal Venopathy: A Clinical and Histopathological Review

Authors: Sourabh Aggarwal, M. Isabel Fiel, Thomas D. Schiano

Published in: Digestive Diseases and Sciences | Issue 10/2013

Login to get access

Abstract

Non-cirrhotic portal hypertension (NCPH) is characterized by the elevation of the portal pressure in the absence of cirrhosis. Obliterative portal venopathy (OPV) as a cause of NCPH is being increasingly diagnosed, especially after recent reports of its occurrence in patients with HIV using didanosine. Patients usually present with episodes of variceal hemorrhage and other features of portal hypertension including jaundice, ascites, encephalopathy and hepatopulmonary syndrome. Hepatic synthetic function is typically well preserved and the laboratory evaluation in OPV patients typically reveals only mild nonspecific hematological abnormalities chiefly related to hypersplenism. Its diagnosis remains a challenge and patients are often mistakenly diagnosed as having cirrhosis. Despite the increasing recognition of OPV, its etiology and pathogenesis are still unclear. A number of etiologies have been proposed including genetic predisposition, recurrent bacterial infections, HIV infection and highly active antiretroviral therapy, an altered immune response, hypercoagulability, and exposure to chemicals and certain medications. Histopathological evaluation remains critical in excluding cirrhosis and other causes of portal hypertension, and is the only way of definitively establishing the diagnosis of OPV. Clinicians should have a high index of suspicion for OPV in patients who present with variceal bleeding and splenomegaly and who do not have other features of cirrhosis. The purpose of this review is to summarize the known etiologies for OPV and its associated clinical aspects and correlations, and to also provide ample histophotomicrographs of OPV to aid in the diagnosis. It will also help raise awareness of this entity amongst pathologists and clinicians alike.
Literature
1.
go back to reference Schouten JN, Garcia-Pagan JC, Valla DC, Janssen HL. Idiopathic noncirrhotic portal hypertension. Hepatology. 2011;54:1071–1081.PubMedCrossRef Schouten JN, Garcia-Pagan JC, Valla DC, Janssen HL. Idiopathic noncirrhotic portal hypertension. Hepatology. 2011;54:1071–1081.PubMedCrossRef
2.
go back to reference Bittencourt PL, Couto CA, Ribeiro DD. Portal vein thrombosis and budd-Chiari syndrome. Hematol Oncol Clin North Am. 2011;25:1049–1066, vi–vii. Bittencourt PL, Couto CA, Ribeiro DD. Portal vein thrombosis and budd-Chiari syndrome. Hematol Oncol Clin North Am. 2011;25:1049–1066, vi–vii.
4.
go back to reference Ameh EA, Nmadu PT. Major complications of omphalitis in neonates and infants. Pediatr Surg Int. 2002;18:413–416.PubMedCrossRef Ameh EA, Nmadu PT. Major complications of omphalitis in neonates and infants. Pediatr Surg Int. 2002;18:413–416.PubMedCrossRef
5.
go back to reference Kumar A, Ahuja CK, Vyas S, et al. Hepatic arteriovenous fistulae: role of interventional radiology. Dig Dis Sci. 2012;57:2703–2712.PubMedCrossRef Kumar A, Ahuja CK, Vyas S, et al. Hepatic arteriovenous fistulae: role of interventional radiology. Dig Dis Sci. 2012;57:2703–2712.PubMedCrossRef
6.
go back to reference Attila T, Datta MW, Sudakoff G, Abu-Hajir M, Massey BT. Intrahepatic portal hypertension secondary to metastatic carcinoma of the prostate. WMJ. 2007;106:34–36.PubMed Attila T, Datta MW, Sudakoff G, Abu-Hajir M, Massey BT. Intrahepatic portal hypertension secondary to metastatic carcinoma of the prostate. WMJ. 2007;106:34–36.PubMed
7.
go back to reference Garcia-Tsao G, Korzenik JR, Young L, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2000;343:931–936.PubMedCrossRef Garcia-Tsao G, Korzenik JR, Young L, et al. Liver disease in patients with hereditary hemorrhagic telangiectasia. N Engl J Med. 2000;343:931–936.PubMedCrossRef
8.
go back to reference Colombo C, Russo MC, Zazzeron L, Romano G. Liver disease in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2006;43(Suppl 1):S49–S55.PubMedCrossRef Colombo C, Russo MC, Zazzeron L, Romano G. Liver disease in cystic fibrosis. J Pediatr Gastroenterol Nutr. 2006;43(Suppl 1):S49–S55.PubMedCrossRef
9.
10.
go back to reference Ebert EC, Kierson M, Hagspiel KD. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol. 2008;103:3184–3192 (quiz 93). Ebert EC, Kierson M, Hagspiel KD. Gastrointestinal and hepatic manifestations of sarcoidosis. Am J Gastroenterol. 2008;103:3184–3192 (quiz 93).
11.
go back to reference Gunay-Aygun M, Font-Montgomery E, Lukose L, et al. Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease. Gastroenterology. 2013;144(112–21):e2.PubMed Gunay-Aygun M, Font-Montgomery E, Lukose L, et al. Characteristics of congenital hepatic fibrosis in a large cohort of patients with autosomal recessive polycystic kidney disease. Gastroenterology. 2013;144(112–21):e2.PubMed
12.
go back to reference Bosch J, Mastai R, Kravetz D, Navasa M, Rodes J. Hemodynamic evaluation of the patient with portal hypertension. Semin Liver Dis. 1986;6:309–317.PubMedCrossRef Bosch J, Mastai R, Kravetz D, Navasa M, Rodes J. Hemodynamic evaluation of the patient with portal hypertension. Semin Liver Dis. 1986;6:309–317.PubMedCrossRef
13.
14.
go back to reference Schiano TD, Uriel A, Dieterich DT, Fiel MI. The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV. Virchows Arch. 2011;458:231–235.PubMedCrossRef Schiano TD, Uriel A, Dieterich DT, Fiel MI. The development of hepatoportal sclerosis and portal hypertension due to didanosine use in HIV. Virchows Arch. 2011;458:231–235.PubMedCrossRef
15.
go back to reference Schiano TD, Kotler DP, Ferran E, Fiel MI. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol. 2007;102:2536–2540.PubMedCrossRef Schiano TD, Kotler DP, Ferran E, Fiel MI. Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol. 2007;102:2536–2540.PubMedCrossRef
16.
go back to reference Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology. 2006;44:7–14.PubMedCrossRef Reshamwala PA, Kleiner DE, Heller T. Nodular regenerative hyperplasia: not all nodules are created equal. Hepatology. 2006;44:7–14.PubMedCrossRef
17.
go back to reference Ravenna P. Banti syndrome (fibrocongestive splenomegaly): definition, classification and pathogenesis. Arch Intern Med. 1940;66:879–892.CrossRef Ravenna P. Banti syndrome (fibrocongestive splenomegaly): definition, classification and pathogenesis. Arch Intern Med. 1940;66:879–892.CrossRef
18.
go back to reference Nayak NC, Ramalingaswami V. Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly. Arch Pathol. 1969;87:359–369.PubMed Nayak NC, Ramalingaswami V. Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly. Arch Pathol. 1969;87:359–369.PubMed
19.
go back to reference Ramalingaswami V, Wig KL, Sama SK. Cirrhosis of the liver in northern India. A clinicopathologic study. Arch Intern Med. 1962;110:350–358.PubMedCrossRef Ramalingaswami V, Wig KL, Sama SK. Cirrhosis of the liver in northern India. A clinicopathologic study. Arch Intern Med. 1962;110:350–358.PubMedCrossRef
20.
go back to reference Basu AK, Boyer J, Bhattacharya R, Mallik KC, Sen Gupta KP. Non-cirrhotic portal fibrosis with portal hypertension: a new syndrome. I. Clinical and function studies and results of operations. Indian J Med Res. 1967;55:336–350.PubMed Basu AK, Boyer J, Bhattacharya R, Mallik KC, Sen Gupta KP. Non-cirrhotic portal fibrosis with portal hypertension: a new syndrome. I. Clinical and function studies and results of operations. Indian J Med Res. 1967;55:336–350.PubMed
21.
go back to reference Boyer JL, Sen Gupta KP, Biswas SK. Idiopathic portal hypertension. Comparison with the portal hypertension of cirrhosis and extrahepatic portal vein obstruction. Ann Intern Med. 1967;66:41–68.PubMedCrossRef Boyer JL, Sen Gupta KP, Biswas SK. Idiopathic portal hypertension. Comparison with the portal hypertension of cirrhosis and extrahepatic portal vein obstruction. Ann Intern Med. 1967;66:41–68.PubMedCrossRef
22.
go back to reference Mikkelsen WP, Edmondson HA, Peters RL, Redeker AG, Reynolds TB. Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg. 1965;162:602–620.PubMedCrossRef Mikkelsen WP, Edmondson HA, Peters RL, Redeker AG, Reynolds TB. Extra- and intrahepatic portal hypertension without cirrhosis (hepatoportal sclerosis). Ann Surg. 1965;162:602–620.PubMedCrossRef
23.
go back to reference Kobayashi Y, Inokuchi K, Saku M. Epidemiology of idiopathic portal hypertension based on a nation-wide survey. In: Suguira M, ed. Report of the ministry of health and welfare research committee on idiopathic portal hypertension. Tokyo: Japan Ministry of Health and Welfare; 1976:10–15. Kobayashi Y, Inokuchi K, Saku M. Epidemiology of idiopathic portal hypertension based on a nation-wide survey. In: Suguira M, ed. Report of the ministry of health and welfare research committee on idiopathic portal hypertension. Tokyo: Japan Ministry of Health and Welfare; 1976:10–15.
24.
go back to reference Tisdale WA, Klatskin G, Glenn WW. Portal hypertension and bleeding esophageal varices; their occurrence in the absence of both intrahepatic and extrahepatic obstruction of the portal vein. N Engl J Med. 1959;261:209–218.PubMedCrossRef Tisdale WA, Klatskin G, Glenn WW. Portal hypertension and bleeding esophageal varices; their occurrence in the absence of both intrahepatic and extrahepatic obstruction of the portal vein. N Engl J Med. 1959;261:209–218.PubMedCrossRef
25.
26.
go back to reference Siderys H, Vellios F. Portal hypertension without cirrhosis or extrahepatic obstruction. Report of a case. Am J Surg. 1964;108:785–789.PubMedCrossRef Siderys H, Vellios F. Portal hypertension without cirrhosis or extrahepatic obstruction. Report of a case. Am J Surg. 1964;108:785–789.PubMedCrossRef
27.
go back to reference Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 30-1989. A 52-year-old man from India with splenomegaly, esophageal varices, and recurrent gastrointestinal bleeding. N Engl J Med. 1989;321:246–253. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 30-1989. A 52-year-old man from India with splenomegaly, esophageal varices, and recurrent gastrointestinal bleeding. N Engl J Med. 1989;321:246–253.
28.
go back to reference Vakili C, Farahvash MJ, Bynum TE. “Endemic” idiopathic portal hypertension: report on 32 patients with non-cirrhotic portal fibrosis. World J Surg. 1992;16:118–124 (discussion 24–25). Vakili C, Farahvash MJ, Bynum TE. “Endemic” idiopathic portal hypertension: report on 32 patients with non-cirrhotic portal fibrosis. World J Surg. 1992;16:118–124 (discussion 24–25).
29.
30.
go back to reference Qureshi H, Kamal S, Khan RA, Zuberi SJ, Alam SE. Differentiation of cirrhotic vs idiopathic portal hypertension using 99mTc-Sn colloid dynamic and static scintigraphy. J Pak Med Assoc. 1991;41:126–129.PubMed Qureshi H, Kamal S, Khan RA, Zuberi SJ, Alam SE. Differentiation of cirrhotic vs idiopathic portal hypertension using 99mTc-Sn colloid dynamic and static scintigraphy. J Pak Med Assoc. 1991;41:126–129.PubMed
32.
go back to reference Dhiman RK, Chawla Y, Vasishta RK, et al. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol. 2002;17:6–16.PubMedCrossRef Dhiman RK, Chawla Y, Vasishta RK, et al. Non-cirrhotic portal fibrosis (idiopathic portal hypertension): experience with 151 patients and a review of the literature. J Gastroenterol Hepatol. 2002;17:6–16.PubMedCrossRef
33.
go back to reference Datta DV. Non-cirrhotic portal fibrosis (‘idiopathic’ portal hypertension in India). J Assoc Phys India. 1976;24:511–527. Datta DV. Non-cirrhotic portal fibrosis (‘idiopathic’ portal hypertension in India). J Assoc Phys India. 1976;24:511–527.
34.
go back to reference Okuda K, Nakashima T, Okudaira M, et al. Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study. Liver. 1982;2:176–192.PubMed Okuda K, Nakashima T, Okudaira M, et al. Liver pathology of idiopathic portal hypertension. Comparison with non-cirrhotic portal fibrosis of India. The Japan idiopathic portal hypertension study. Liver. 1982;2:176–192.PubMed
35.
go back to reference Iber FL. Obliterative portal venopathy of the liver and “idiopathic portal hypertension”. Ann Intern Med. 1969;71:660–661.PubMedCrossRef Iber FL. Obliterative portal venopathy of the liver and “idiopathic portal hypertension”. Ann Intern Med. 1969;71:660–661.PubMedCrossRef
36.
go back to reference Villeneuve JP, Huet PM, Joly JG, et al. Idiopathic portal hypertension. Am J Med. 1976;61:459–464.PubMedCrossRef Villeneuve JP, Huet PM, Joly JG, et al. Idiopathic portal hypertension. Am J Med. 1976;61:459–464.PubMedCrossRef
37.
go back to reference Kingham JG, Levison DA, Stansfeld AG, Dawson AM. Non-cirrhotic intrahepatic portal hypertension: a long term follow-up study. Q J Med. 1981;50:259–268.PubMed Kingham JG, Levison DA, Stansfeld AG, Dawson AM. Non-cirrhotic intrahepatic portal hypertension: a long term follow-up study. Q J Med. 1981;50:259–268.PubMed
38.
go back to reference Eapen CE, Nightingale P, Hubscher SG, et al. Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors. Dig Dis Sci. 2011;56:227–235.PubMedCrossRef Eapen CE, Nightingale P, Hubscher SG, et al. Non-cirrhotic intrahepatic portal hypertension: associated gut diseases and prognostic factors. Dig Dis Sci. 2011;56:227–235.PubMedCrossRef
39.
go back to reference Okuda K. Non-cirrhotic portal hypertension versus idiopathic portal hypertension. J Gastroenterol Hepatol. 2002;17(Suppl 3):S204–S213.PubMedCrossRef Okuda K. Non-cirrhotic portal hypertension versus idiopathic portal hypertension. J Gastroenterol Hepatol. 2002;17(Suppl 3):S204–S213.PubMedCrossRef
40.
go back to reference Kochin I, Magid M, Arnon R, Glasscock A, Kerkar N, Miloh T. Variceal bleeding in an adolescent with HIV diagnosed with hepatoportal sclerosis and nodular regenerative hyperplasia. J Pediatr Gastroenterol Nutr. 2010;50:340–343.PubMedCrossRef Kochin I, Magid M, Arnon R, Glasscock A, Kerkar N, Miloh T. Variceal bleeding in an adolescent with HIV diagnosed with hepatoportal sclerosis and nodular regenerative hyperplasia. J Pediatr Gastroenterol Nutr. 2010;50:340–343.PubMedCrossRef
41.
go back to reference Girard M, Amiel J, Fabre M, Pariente D, Lyonnet S, Jacquemin E. Adams-Oliver syndrome and hepatoportal sclerosis: occasional association or common mechanism? Am J Med Genet A. 2005;135:186–189.PubMed Girard M, Amiel J, Fabre M, Pariente D, Lyonnet S, Jacquemin E. Adams-Oliver syndrome and hepatoportal sclerosis: occasional association or common mechanism? Am J Med Genet A. 2005;135:186–189.PubMed
42.
go back to reference Roulot D, Degott C, Chazouilleres O, et al. Vascular involvement of the liver in Turner’s syndrome. Hepatology. 2004;39:239–247.PubMedCrossRef Roulot D, Degott C, Chazouilleres O, et al. Vascular involvement of the liver in Turner’s syndrome. Hepatology. 2004;39:239–247.PubMedCrossRef
43.
go back to reference Sarin SK, Mehra NK, Agarwal A, Malhotra V, Anand BS, Taneja V. Familial aggregation in noncirrhotic portal fibrosis: a report of four families. Am J Gastroenterol. 1987;82:1130–1133.PubMed Sarin SK, Mehra NK, Agarwal A, Malhotra V, Anand BS, Taneja V. Familial aggregation in noncirrhotic portal fibrosis: a report of four families. Am J Gastroenterol. 1987;82:1130–1133.PubMed
44.
go back to reference Kono K, Ohnishi K, Omata M, et al. Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits. Gastroenterology. 1988;94:787–796.PubMed Kono K, Ohnishi K, Omata M, et al. Experimental portal fibrosis produced by intraportal injection of killed nonpathogenic Escherichia coli in rabbits. Gastroenterology. 1988;94:787–796.PubMed
45.
go back to reference Sugita S, Ohnishi K, Saito M, Okuda K. Splanchnic hemodynamics in portal hypertensive dogs with portal fibrosis. Am J Physiol. 1987;252:G748–G754.PubMed Sugita S, Ohnishi K, Saito M, Okuda K. Splanchnic hemodynamics in portal hypertensive dogs with portal fibrosis. Am J Physiol. 1987;252:G748–G754.PubMed
46.
go back to reference Kathayat R, Pandey GK, Malhotra V, Omanwar S, Sharma BK, Sarin SK. Rabbit model of non-cirrhotic portal fibrosis with repeated immunosensitization by rabbit splenic extract. J Gastroenterol Hepatol. 2002;17:1312–1316.PubMedCrossRef Kathayat R, Pandey GK, Malhotra V, Omanwar S, Sharma BK, Sarin SK. Rabbit model of non-cirrhotic portal fibrosis with repeated immunosensitization by rabbit splenic extract. J Gastroenterol Hepatol. 2002;17:1312–1316.PubMedCrossRef
47.
go back to reference Tuyama AC, Krakauer M, Alzaabi M, Fiel MI, Legnani P, Schiano TD. Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn’s disease. J Crohns Colitis. 2013;7:590–593.PubMedCrossRef Tuyama AC, Krakauer M, Alzaabi M, Fiel MI, Legnani P, Schiano TD. Mercaptopurine-induced hepatoportal sclerosis in a patient with Crohn’s disease. J Crohns Colitis. 2013;7:590–593.PubMedCrossRef
48.
go back to reference Guha Mazumdar DN, Das Gupta J. Arsenic and non-cirrhotic portal hypertension. J Hepatol. 1991;13:376. Guha Mazumdar DN, Das Gupta J. Arsenic and non-cirrhotic portal hypertension. J Hepatol. 1991;13:376.
49.
go back to reference Key NS, Kelly PM, Emerson PM, Chapman RW, Allan NC, McGee JO. Oesophageal varices associated with busulphan-thioguanine combination therapy for chronic myeloid leukaemia. Lancet. 1987;2:1050–1052.PubMedCrossRef Key NS, Kelly PM, Emerson PM, Chapman RW, Allan NC, McGee JO. Oesophageal varices associated with busulphan-thioguanine combination therapy for chronic myeloid leukaemia. Lancet. 1987;2:1050–1052.PubMedCrossRef
50.
go back to reference Nevens F, Fevery J, Van Steenbergen W, Sciot R, Desmet V, De Groote J. Arsenic and non-cirrhotic portal hypertension. A report of eight cases. J Hepatol. 1990;11:80–85.PubMedCrossRef Nevens F, Fevery J, Van Steenbergen W, Sciot R, Desmet V, De Groote J. Arsenic and non-cirrhotic portal hypertension. A report of eight cases. J Hepatol. 1990;11:80–85.PubMedCrossRef
51.
go back to reference Saifee S, Joelson D, Braude J, et al. Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection. Clin Gastroenterol Hepatol. 2008;6:1167–1169.PubMedCrossRef Saifee S, Joelson D, Braude J, et al. Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection. Clin Gastroenterol Hepatol. 2008;6:1167–1169.PubMedCrossRef
52.
go back to reference Vispo E, Moreno A, Maida I, et al. Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings. AIDS. 2010;24:1171–1176.PubMedCrossRef Vispo E, Moreno A, Maida I, et al. Noncirrhotic portal hypertension in HIV-infected patients: unique clinical and pathological findings. AIDS. 2010;24:1171–1176.PubMedCrossRef
53.
go back to reference Kovari H, Ledergerber B, Peter U, et al. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study. Clin Infect Dis. 2009;49:626–635.PubMedCrossRef Kovari H, Ledergerber B, Peter U, et al. Association of noncirrhotic portal hypertension in HIV-infected persons and antiretroviral therapy with didanosine: a nested case-control study. Clin Infect Dis. 2009;49:626–635.PubMedCrossRef
54.
go back to reference Mallet VO, Varthaman A, Lasne D, et al. Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients. AIDS. 2009;23:1511–1518.PubMedCrossRef Mallet VO, Varthaman A, Lasne D, et al. Acquired protein S deficiency leads to obliterative portal venopathy and to compensatory nodular regenerative hyperplasia in HIV-infected patients. AIDS. 2009;23:1511–1518.PubMedCrossRef
55.
go back to reference Di Minno MN, Iervolino S, Peluso R, Scarpa R, Di Minno G. Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-alpha blockers and traditional disease-modifying antirheumatic drugs. Arterioscler Thromb Vasc Biol. 2011;31:705–712.PubMedCrossRef Di Minno MN, Iervolino S, Peluso R, Scarpa R, Di Minno G. Carotid intima-media thickness in psoriatic arthritis: differences between tumor necrosis factor-alpha blockers and traditional disease-modifying antirheumatic drugs. Arterioscler Thromb Vasc Biol. 2011;31:705–712.PubMedCrossRef
56.
go back to reference Nayyar AK, Sharma BK, Sarin SK, Malhotra P, Broor SL, Sachdev G. Characterization of peripheral blood lymphocytes in patients with non-cirrhotic portal fibrosis: a comparison with cirrhotics and healthy controls. J Gastroenterol Hepatol. 1990;5:554–559.PubMedCrossRef Nayyar AK, Sharma BK, Sarin SK, Malhotra P, Broor SL, Sachdev G. Characterization of peripheral blood lymphocytes in patients with non-cirrhotic portal fibrosis: a comparison with cirrhotics and healthy controls. J Gastroenterol Hepatol. 1990;5:554–559.PubMedCrossRef
57.
go back to reference Tokushige K, Komatsu T, Ohzu K, Yamauchi K, Obata H. A defective autologous mixed lymphocyte reaction in patients with idiopathic portal hypertension. J Gastroenterol Hepatol. 1992;7:270–273.PubMedCrossRef Tokushige K, Komatsu T, Ohzu K, Yamauchi K, Obata H. A defective autologous mixed lymphocyte reaction in patients with idiopathic portal hypertension. J Gastroenterol Hepatol. 1992;7:270–273.PubMedCrossRef
58.
go back to reference Saito K, Nakanuma Y, Takegoshi K, et al. Non-specific immunological abnormalities and association of autoimmune diseases in idiopathic portal hypertension. A study by questionnaire. Hepatogastroenterology. 1993;40:163–166.PubMed Saito K, Nakanuma Y, Takegoshi K, et al. Non-specific immunological abnormalities and association of autoimmune diseases in idiopathic portal hypertension. A study by questionnaire. Hepatogastroenterology. 1993;40:163–166.PubMed
59.
go back to reference Inagaki H, Nonami T, Kawagoe T, et al. Idiopathic portal hypertension associated with systemic lupus erythematosus. J Gastroenterol. 2000;35:235–239.PubMedCrossRef Inagaki H, Nonami T, Kawagoe T, et al. Idiopathic portal hypertension associated with systemic lupus erythematosus. J Gastroenterol. 2000;35:235–239.PubMedCrossRef
60.
go back to reference Tsuneyama K, Harada K, Katayanagi K, et al. Overlap of idiopathic portal hypertension and scleroderma: report of two autopsy cases and a review of literature. J Gastroenterol Hepatol. 2002;17:217–223.PubMedCrossRef Tsuneyama K, Harada K, Katayanagi K, et al. Overlap of idiopathic portal hypertension and scleroderma: report of two autopsy cases and a review of literature. J Gastroenterol Hepatol. 2002;17:217–223.PubMedCrossRef
61.
go back to reference Umeyama K, Yui S, Fukamizu A, Yoshikawa K, Yamashita T. Idiopathic portal hypertension associated with progressive systemic sclerosis. Am J Gastroenterol. 1982;77:645–648.PubMed Umeyama K, Yui S, Fukamizu A, Yoshikawa K, Yamashita T. Idiopathic portal hypertension associated with progressive systemic sclerosis. Am J Gastroenterol. 1982;77:645–648.PubMed
62.
go back to reference Austin A, Campbell E, Lane P, Elias E. Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody. Gut. 2004;53:1032–1034.PubMedCrossRef Austin A, Campbell E, Lane P, Elias E. Nodular regenerative hyperplasia of the liver and coeliac disease: potential role of IgA anticardiolipin antibody. Gut. 2004;53:1032–1034.PubMedCrossRef
63.
go back to reference Malamut G, Ziol M, Suarez F, et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol. 2008;48:74–82.PubMedCrossRef Malamut G, Ziol M, Suarez F, et al. Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol. 2008;48:74–82.PubMedCrossRef
64.
go back to reference Okabayashi A. Experimental production of non-cirrhotic portal hypertension and splenomegaly with prolonged stimulation. In: Okuda K, Omata M, eds. Idiopathic portal hypertension. Tokyo: University of Tokyo Press; 1983:197–205. Okabayashi A. Experimental production of non-cirrhotic portal hypertension and splenomegaly with prolonged stimulation. In: Okuda K, Omata M, eds. Idiopathic portal hypertension. Tokyo: University of Tokyo Press; 1983:197–205.
65.
go back to reference Abraham SC, Kamath PS, Eghtesad B, Demetris AJ, Krasinskas AM. Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy. Am J Surg Pathol. 2006;30:1454–1461.PubMedCrossRef Abraham SC, Kamath PS, Eghtesad B, Demetris AJ, Krasinskas AM. Liver transplantation in precirrhotic biliary tract disease: portal hypertension is frequently associated with nodular regenerative hyperplasia and obliterative portal venopathy. Am J Surg Pathol. 2006;30:1454–1461.PubMedCrossRef
66.
go back to reference Portmann B, Zen Y. Inflammatory disease of the bile ducts-cholangiopathies: liver biopsy challenge and clinicopathological correlation. Histopathology. 2012;60:236–248.PubMedCrossRef Portmann B, Zen Y. Inflammatory disease of the bile ducts-cholangiopathies: liver biopsy challenge and clinicopathological correlation. Histopathology. 2012;60:236–248.PubMedCrossRef
67.
go back to reference Hillaire S, Bonte E, Denninger MH, et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut. 2002;51:275–280.PubMedCrossRef Hillaire S, Bonte E, Denninger MH, et al. Idiopathic non-cirrhotic intrahepatic portal hypertension in the West: a re-evaluation in 28 patients. Gut. 2002;51:275–280.PubMedCrossRef
68.
go back to reference Koksal AS, Koklu S, Ibis M, et al. Clinical features, serum interleukin-6, and interferon-gamma levels of 34 Turkish patients with hepatoportal sclerosis. Dig Dis Sci. 2007;52:3493–3498.PubMedCrossRef Koksal AS, Koklu S, Ibis M, et al. Clinical features, serum interleukin-6, and interferon-gamma levels of 34 Turkish patients with hepatoportal sclerosis. Dig Dis Sci. 2007;52:3493–3498.PubMedCrossRef
69.
go back to reference Okuda K. Non-cirrhotic portal hypertension: why is it so common in India? J Gastroenterol Hepatol. 2002;17:1–5.PubMedCrossRef Okuda K. Non-cirrhotic portal hypertension: why is it so common in India? J Gastroenterol Hepatol. 2002;17:1–5.PubMedCrossRef
70.
go back to reference Okudaira M, Ohbu M, Okuda K. Idiopathic portal hypertension and its pathology. Semin Liver Dis. 2002;22:59–72.PubMedCrossRef Okudaira M, Ohbu M, Okuda K. Idiopathic portal hypertension and its pathology. Semin Liver Dis. 2002;22:59–72.PubMedCrossRef
71.
go back to reference Ohnishi K, Saito M, Sato S, et al. Portal hemodynamics in idiopathic portal hypertension (Banti’s syndrome). Comparison with chronic persistent hepatitis and normal subjects. Gastroenterology. 1987;92:751–758.PubMed Ohnishi K, Saito M, Sato S, et al. Portal hemodynamics in idiopathic portal hypertension (Banti’s syndrome). Comparison with chronic persistent hepatitis and normal subjects. Gastroenterology. 1987;92:751–758.PubMed
72.
go back to reference Lindor K, Rakela J, Perrault J, Van Heerden J. Noncirrhotic portal hypertension due to lymphoma. Reversal following splenectomy. Dig Dis Sci. 1987;32:1056–1058.PubMedCrossRef Lindor K, Rakela J, Perrault J, Van Heerden J. Noncirrhotic portal hypertension due to lymphoma. Reversal following splenectomy. Dig Dis Sci. 1987;32:1056–1058.PubMedCrossRef
73.
go back to reference Morikawa H, Tamori A, Nishiguchi S, et al. Expression of connective tissue growth factor in the human liver with idiopathic portal hypertension. Mol Med. 2007;13:240–245.PubMedCrossRef Morikawa H, Tamori A, Nishiguchi S, et al. Expression of connective tissue growth factor in the human liver with idiopathic portal hypertension. Mol Med. 2007;13:240–245.PubMedCrossRef
74.
go back to reference Dabritz J, Worch J, Materna U, et al. Life-threatening hypersplenism due to idiopathic portal hypertension in early childhood: case report and review of the literature. BMC Gastroenterol. 2010;10:122.PubMedCrossRef Dabritz J, Worch J, Materna U, et al. Life-threatening hypersplenism due to idiopathic portal hypertension in early childhood: case report and review of the literature. BMC Gastroenterol. 2010;10:122.PubMedCrossRef
75.
go back to reference Sato Y, Sawada S, Kozaka K, et al. Significance of enhanced expression of nitric oxide syntheses in splenic sinus lining cells in altered portal hemodynamics of idiopathic portal hypertension. Dig Dis Sci. 2007;52:1987–1994.PubMedCrossRef Sato Y, Sawada S, Kozaka K, et al. Significance of enhanced expression of nitric oxide syntheses in splenic sinus lining cells in altered portal hemodynamics of idiopathic portal hypertension. Dig Dis Sci. 2007;52:1987–1994.PubMedCrossRef
76.
go back to reference Kamath PS, Tyce GM, Miller VM, Edwards BS, Rorie DK. Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension. Hepatology. 1999;30:401–407.PubMedCrossRef Kamath PS, Tyce GM, Miller VM, Edwards BS, Rorie DK. Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension. Hepatology. 1999;30:401–407.PubMedCrossRef
77.
go back to reference Yamaguchi E, Yamanoi A, Ono T, Nagasue N. Experimental investigation of the role of endothelin-1 in idiopathic portal hypertension. J Gastroenterol Hepatol. 2007;22:1134–1140.PubMedCrossRef Yamaguchi E, Yamanoi A, Ono T, Nagasue N. Experimental investigation of the role of endothelin-1 in idiopathic portal hypertension. J Gastroenterol Hepatol. 2007;22:1134–1140.PubMedCrossRef
78.
go back to reference Fiel MI, Schiano TD, Suriawinata A, Emre S. Portal hypertension and hepatopulmonary syndrome in a middle-aged man with hepatitis B infection. Semin Liver Dis. 2000;20:391–395.PubMedCrossRef Fiel MI, Schiano TD, Suriawinata A, Emre S. Portal hypertension and hepatopulmonary syndrome in a middle-aged man with hepatitis B infection. Semin Liver Dis. 2000;20:391–395.PubMedCrossRef
79.
go back to reference Cazals-Hatem D, Hillaire S, Rudler M, et al. Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J Hepatol. 2011;54:455–461.PubMedCrossRef Cazals-Hatem D, Hillaire S, Rudler M, et al. Obliterative portal venopathy: portal hypertension is not always present at diagnosis. J Hepatol. 2011;54:455–461.PubMedCrossRef
80.
go back to reference Okuda K, Kono K, Ohnishi K, et al. Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology. 1984;86:600–610.PubMed Okuda K, Kono K, Ohnishi K, et al. Clinical study of eighty-six cases of idiopathic portal hypertension and comparison with cirrhosis with splenomegaly. Gastroenterology. 1984;86:600–610.PubMed
81.
go back to reference Sarin SK, Kumar A, Chawla YK, et al. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int. 2007;1:398–413.PubMedCrossRef Sarin SK, Kumar A, Chawla YK, et al. Noncirrhotic portal fibrosis/idiopathic portal hypertension: APASL recommendations for diagnosis and treatment. Hepatol Int. 2007;1:398–413.PubMedCrossRef
82.
go back to reference Sarin SK, Kapoor D. Non-cirrhotic portal fibrosis: current concepts and management. J Gastroenterol Hepatol. 2002;17:526–534.PubMedCrossRef Sarin SK, Kapoor D. Non-cirrhotic portal fibrosis: current concepts and management. J Gastroenterol Hepatol. 2002;17:526–534.PubMedCrossRef
83.
go back to reference Okuda M, Nakshima T, Kameda H, Sugirua M, Ohinshi K, Kobyashi M. Idiopathic noncirrhotic portal hypertension: a national study, Ministry of Health and Welfare Research Committee on Idiopathic Portal Hypertension. In: Brunner H, Thaler H, eds. Hepatology: a festschrift for Hans Popper. New York: Raven; 1985. Okuda M, Nakshima T, Kameda H, Sugirua M, Ohinshi K, Kobyashi M. Idiopathic noncirrhotic portal hypertension: a national study, Ministry of Health and Welfare Research Committee on Idiopathic Portal Hypertension. In: Brunner H, Thaler H, eds. Hepatology: a festschrift for Hans Popper. New York: Raven; 1985.
84.
go back to reference Bernard PH, Le Bail B, Cransac M, et al. Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation. J Hepatol. 1995;22:495–499.PubMedCrossRef Bernard PH, Le Bail B, Cransac M, et al. Progression from idiopathic portal hypertension to incomplete septal cirrhosis with liver failure requiring liver transplantation. J Hepatol. 1995;22:495–499.PubMedCrossRef
85.
go back to reference Krasinskas AM, Eghtesad B, Kamath PS, Demetris AJ, Abraham SC. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl. 2005;11:627–634 (discussion 10–11). Krasinskas AM, Eghtesad B, Kamath PS, Demetris AJ, Abraham SC. Liver transplantation for severe intrahepatic noncirrhotic portal hypertension. Liver Transpl. 2005;11:627–634 (discussion 10–11).
86.
go back to reference Francavilla A, Azzarone A, Carrieri G, et al. Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors. Hepatology. 1992;16:1267–1270.PubMedCrossRef Francavilla A, Azzarone A, Carrieri G, et al. Effect on the canine Eck fistula liver of intraportal TGF-beta alone or with hepatic growth factors. Hepatology. 1992;16:1267–1270.PubMedCrossRef
87.
go back to reference Fiel MI, Thung SN, Hytiroglou P, Emre S, Schiano TD. Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis. Am J Surg Pathol.. 2007;31:607–614.CrossRef Fiel MI, Thung SN, Hytiroglou P, Emre S, Schiano TD. Liver failure and need for liver transplantation in patients with advanced hepatoportal sclerosis. Am J Surg Pathol.. 2007;31:607–614.CrossRef
88.
go back to reference Bajaj JS, Bhattacharjee J, Sarin SK. Coagulation profile and platelet function in patients with extrahepatic portal vein obstruction and non-cirrhotic portal fibrosis. J Gastroenterol Hepatol. 2001;16:641–646.PubMedCrossRef Bajaj JS, Bhattacharjee J, Sarin SK. Coagulation profile and platelet function in patients with extrahepatic portal vein obstruction and non-cirrhotic portal fibrosis. J Gastroenterol Hepatol. 2001;16:641–646.PubMedCrossRef
89.
go back to reference Sarin SK, Kumar A. Noncirrhotic portal hypertension. Clin Liver Dis. 2006;10:627–51, x. Sarin SK, Kumar A. Noncirrhotic portal hypertension. Clin Liver Dis. 2006;10:627–51, x.
90.
go back to reference Sarin SK, Sethi KK, Nanda R. Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis. Gut. 1987;28:260–266.PubMedCrossRef Sarin SK, Sethi KK, Nanda R. Measurement and correlation of wedged hepatic, intrahepatic, intrasplenic and intravariceal pressures in patients with cirrhosis of liver and non-cirrhotic portal fibrosis. Gut. 1987;28:260–266.PubMedCrossRef
91.
go back to reference Seijo S, Reverter E, Berzigotti A, et al. Idiopathic portal hypertension: impact of hepatic vein catheterization and transient elastography on its diagnosis. J Hepatol. 2010;52:S172.CrossRef Seijo S, Reverter E, Berzigotti A, et al. Idiopathic portal hypertension: impact of hepatic vein catheterization and transient elastography on its diagnosis. J Hepatol. 2010;52:S172.CrossRef
92.
go back to reference Krishnan P, Fiel MI, Rosenkrantz AB, et al. Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation. Am J Roentgenol. 2012;198:370–376.CrossRef Krishnan P, Fiel MI, Rosenkrantz AB, et al. Hepatoportal sclerosis: CT and MRI appearance with histopathologic correlation. Am J Roentgenol. 2012;198:370–376.CrossRef
93.
go back to reference Glatard AS, Hillaire S, d’Assignies G, et al. Obliterative portal venopathy: findings at CT imaging. Radiology. 2012;263:741–750.PubMedCrossRef Glatard AS, Hillaire S, d’Assignies G, et al. Obliterative portal venopathy: findings at CT imaging. Radiology. 2012;263:741–750.PubMedCrossRef
94.
go back to reference Nakanuma Y, Hoso M, Sasaki M, et al. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology. 1996;28:195–204.PubMedCrossRef Nakanuma Y, Hoso M, Sasaki M, et al. Histopathology of the liver in non-cirrhotic portal hypertension of unknown aetiology. Histopathology. 1996;28:195–204.PubMedCrossRef
95.
go back to reference Nakanuma Y, Tsuneyama K, Ohbu M, Katayanagi K. Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract. 2001;197:65–76.PubMedCrossRef Nakanuma Y, Tsuneyama K, Ohbu M, Katayanagi K. Pathology and pathogenesis of idiopathic portal hypertension with an emphasis on the liver. Pathol Res Pract. 2001;197:65–76.PubMedCrossRef
96.
go back to reference Nakanuma Y, Kouda W, Nakano T, Uneno K, Tachibana S, Araki I. A case report of early idiopathic portal hypertension. Pathol Res Pract. 2001;197:759–763 (discussion 65–67). Nakanuma Y, Kouda W, Nakano T, Uneno K, Tachibana S, Araki I. A case report of early idiopathic portal hypertension. Pathol Res Pract. 2001;197:759–763 (discussion 65–67).
97.
go back to reference Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology. 1990;11:787–797.PubMedCrossRef Wanless IR. Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology. 1990;11:787–797.PubMedCrossRef
98.
go back to reference Ludwig J, Hashimoto E, Obata H, Baldus WP. Idiopathic portal hypertension; a histopathological study of 26 Japanese cases. Histopathology. 1993;22:227–234.PubMedCrossRef Ludwig J, Hashimoto E, Obata H, Baldus WP. Idiopathic portal hypertension; a histopathological study of 26 Japanese cases. Histopathology. 1993;22:227–234.PubMedCrossRef
99.
go back to reference Sciot R, Staessen D, Van Damme B, et al. Incomplete septal cirrhosis: histopathological aspects. Histopathology. 1988;13:593–603.PubMedCrossRef Sciot R, Staessen D, Van Damme B, et al. Incomplete septal cirrhosis: histopathological aspects. Histopathology. 1988;13:593–603.PubMedCrossRef
100.
go back to reference Chandra R, Kapoor D, Tharakan A, Chaudhary A, Sarin SK. Portal biliopathy. J Gastroenterol Hepatol. 2001;16:1086–1092.PubMedCrossRef Chandra R, Kapoor D, Tharakan A, Chaudhary A, Sarin SK. Portal biliopathy. J Gastroenterol Hepatol. 2001;16:1086–1092.PubMedCrossRef
101.
go back to reference Bombardieri G, Conti LR. Pathophysiology of liver circulation with an overview of medical and invasive treatments. Rays. 1997;22:196–210.PubMed Bombardieri G, Conti LR. Pathophysiology of liver circulation with an overview of medical and invasive treatments. Rays. 1997;22:196–210.PubMed
102.
go back to reference Graziadei IW, Wiesner RH, Marotta PJ, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology. 1999;30:1121–1127.PubMedCrossRef Graziadei IW, Wiesner RH, Marotta PJ, et al. Long-term results of patients undergoing liver transplantation for primary sclerosing cholangitis. Hepatology. 1999;30:1121–1127.PubMedCrossRef
103.
go back to reference Ruemmele P, Hofstaedter F, Gelbmann CM. Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol. 2009;6:287–295.PubMedCrossRef Ruemmele P, Hofstaedter F, Gelbmann CM. Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol. 2009;6:287–295.PubMedCrossRef
Metadata
Title
Obliterative Portal Venopathy: A Clinical and Histopathological Review
Authors
Sourabh Aggarwal
M. Isabel Fiel
Thomas D. Schiano
Publication date
01-10-2013
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 10/2013
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-013-2736-4

Other articles of this Issue 10/2013

Digestive Diseases and Sciences 10/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.